drugset / Trial / NCT00545324
First Step With Singulair® Therapy (0476-323)
RandomizedParallel-groupOpen-labelTreatment
Summary
In adult patients with mild persistent asthma, singulair® 10 mg will be at least as effective as low dose Inhaled Corticosteroids (ICS) in improving asthma symptom control or satisfaction over a 6 week comparison period.
Timeline
- Start
- 2002-09
- Primary completion
- 2003-12
- Completion
- 2003-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone | Other / unclassified | — | Inhaled |
| Subject | Montelukast | Other / unclassified | 10 mg | — |